8 things to know about drug-resistant tuberculosis

by Sandeep Juneja, Senior Vice President, Market Access, TB Alliance

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment

by MedAccess, Viatris and TB Alliance

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

by BASF and MedAccess

Five key lessons from our first five years

by MedAccess

Professor Helen Rees appointed MedAccess Board Chair

by MedAccess

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

by MedAccess

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

by MedAccess

The reality of undiagnosed syphilis for mothers and babies

by Laura Mundy, External Relations Associate

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

by MedAccess, Unitaid, CHAI and The Aurum Institute

5 things you should know about HIV self-testing

by Clinton Health Access Initiative (CHAI)

Subscribe to our newsletter

Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible.